Singapore markets closed

Wave Life Sciences Ltd. (WVE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
5.84-0.62 (-9.60%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close6.46
Open6.48
Bid5.86 x 800
Ask5.84 x 4000
Day's range5.79 - 6.49
52-week range4.82 - 19.98
Volume279,513
Avg. volume669,733
Market cap293.83M
Beta (5Y monthly)0.35
PE ratio (TTM)N/A
EPS (TTM)-3.38
Earnings date10 Aug 2021 - 16 Aug 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est9.14
  • Wave Life Sciences (WVE) Reports Q1 Loss, Misses Revenue Estimates
    Zacks

    Wave Life Sciences (WVE) Reports Q1 Loss, Misses Revenue Estimates

    Wave Life Sciences (WVE) delivered earnings and revenue surprises of -53.57% and -100.00%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

  • Here's Why Wave Life Sciences Crashed Today
    Motley Fool

    Here's Why Wave Life Sciences Crashed Today

    Shares of Wave Life Sciences (NASDAQ: WVE) are down 29% at 1:29 p.m. EDT after the company announced that WVE-120102 and WVE-120101, two of its drugs to treat Huntington's disease, failed to show an effect in early stage clinical trials. Huntington's disease is caused by different mutations in the huntingtin protein. WVE-120101 and WVE-120102 are designed to reduce the expression of mutant huntingtin protein (mHTT) for patients with the SNP1 and SNP2 mutations, respectively.

  • Are Options Traders Betting on a Big Move in Wave Life Sciences (WVE) Stock?
    Zacks

    Are Options Traders Betting on a Big Move in Wave Life Sciences (WVE) Stock?

    Investors need to pay close attention to Wave Life Sciences (WVE) stock based on the movements in the options market lately.